Since its inception in 1992, Eurofins bioskin has been recognised as a valuable partner for clinical trials in dermatological indications. Starting as a small Contract Research Organization (CRO) specialised in conducting early phase safety and efficacy trials, Eurofins bioskin has grown into a full-service CRO offering global dermatologic consulting and regulatory services and all services for management of Phase I-IV drug trials and medical device studies. Eurofins bioskin is headquartered in Hamburg, Germany.

As of August 1, 2021 Eurofins bioskin became part of the Eurofins network of companies. By joining the Eurofins network, we strengthened our position as a leading provider of clinical dermatological trials for pharmaceuticals and medical devices.

We are unique in our understanding and capabilities for both early and late phase development of dermatological and related products. A core expertise is interpretation of study results, integrating biophysical measurement methods to deliver objective data about skin function and structure to support traditional clinical endpoints. For global early and late phase studies Eurofins bioskin partners with selected, reliable partners throughout Western, Central & Eastern Europe, US, Canada, and Latin America.